Found 17 matching trials
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) PHASE2 Single-arm, single site, open label study of the effects of parenteral test...
Show More Location
Sibley Memorial Hospital
Learn More & Join Trial
HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients PHASE3 The primary purpose of this study is to evaluate the efficacy of HC-1119 as...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer PHASE3 This study aims to compare the efficacy and safety of rezvilutamide with en...
Show More Location
The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital
Learn More & Join Trial
Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer PHASE2 The purpose of this study is to determine if enzalutamide is safe and effec...
Show More Location
Rocky Mountain Cancer Centers
Learn More & Join Trial
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer PHASE4 The objective of this study was to evaluate the efficacy and safety of enza...
Show More Learn More & Join Trial
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients PHASE1 A multiple dose relative bioavailability study in patients with prostate ca...
Show More Location
University of Colorado - Anschutz Medical Campus
Learn More & Join Trial
Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy. PHASE2 The objective of this study is to compare the efficacy and safety of enzalu...
Show More Location
Osaka City University Graduate School of Medicine
Learn More & Join Trial
Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance PHASE2 Asymptomatic men with progressive metastatic Castration-resistant prostate ...
Show More Location
Unversity of Alabama
Learn More & Join Trial
Combination Study of AZD5069 and Enzalutamide. PHASE1 ACE is a multi-centre proof of concept Phase I/II trial of the CXCR2 antago...
Show More Location
Bellinzona Hospital
Learn More & Join Trial
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression PHASE2 Asymptomatic men without pain due to prostate cancer progressing with metas...
Show More Location
University of California, San Diego (UCSD)
Learn More & Join Trial